Liv.52 HB smother hepatitis B surface antigen (HBsAg) and clears the hepatitis B infection (HBV) by switch transcriptase hindrance. It essentially brings down the in general viral load in perpetual hepatitis B disease. Further, a half year expanded treatment gives relatively better outcomes as far as viral leeway.
Liv.52 HB turns around the oxidative harm of hepatocytes and applies an in general hepatoprotective activity. It additionally renormalizes liver capacities. Liv 52 HB standardizes liver protein levels and reestablishes the hepatic glycogen levels.